atovaquone
Generic: atovaquone
Labeler: lupin pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
atovaquone
Generic Name
atovaquone
Labeler
lupin pharmaceuticals, inc.
Dosage Form
SUSPENSION
Routes
Active Ingredients
atovaquone 750 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
70748-299
Product ID
70748-299_26a9360d-7db4-42fe-b9d2-ecddfe369d2e
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210692
Listing Expiration
2026-12-31
Marketing Start
2021-06-01
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
70748299
Hyphenated Format
70748-299
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
atovaquone (source: ndc)
Generic Name
atovaquone (source: ndc)
Application Number
ANDA210692 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 750 mg/5mL
Packaging
- 1 BOTTLE in 1 CARTON (70748-299-01) / 210 mL in 1 BOTTLE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "26a9360d-7db4-42fe-b9d2-ecddfe369d2e", "openfda": {"nui": ["N0000175482", "N0000175485"], "unii": ["Y883P1Z2LT"], "rxcui": ["308429"], "spl_set_id": ["03ddcc33-729c-4d46-ae6b-2ee47978ba16"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (70748-299-01) / 210 mL in 1 BOTTLE", "package_ndc": "70748-299-01", "marketing_start_date": "20210601"}], "brand_name": "ATOVAQUONE", "product_id": "70748-299_26a9360d-7db4-42fe-b9d2-ecddfe369d2e", "dosage_form": "SUSPENSION", "pharm_class": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "product_ndc": "70748-299", "generic_name": "ATOVAQUONE", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ATOVAQUONE", "active_ingredients": [{"name": "ATOVAQUONE", "strength": "750 mg/5mL"}], "application_number": "ANDA210692", "marketing_category": "ANDA", "marketing_start_date": "20210601", "listing_expiration_date": "20261231"}